Creating a free account will enable you to subscribe to our daily and weekly email newsletters, as well as customize your reading experience to show only the categories most relevant to you.
Signing up only take a few minutes, so why not give it a try and see what you've been missing out on.
The current study was supported by grants from the NCI (F31CA126474), NIH (numbers CA101642, CA140933, CA104825, CA110793, CA109298, P50CA083639, P50CA098258, CA128797, RC2GM092599, U54CA96300, and U54CA96297), the Ovarian Cancer Research Fund, Zarrow Foundation, Department of Defense (numbers OC073399, W81XWH-10-1-0158, OC100237, and BC085265) Betty Ann Asche Murray Distinguished Professorship, the Marcus Foundation, RGK Foundation, Gilder Foundation, the estate of C.G. Johnson Jr., the Laura and John Arnold Foundation and the Blanton-Davis Ovarian Cancer Research Programme.
Co-authors of the paper from MD Anderson included Guillermo N. Armaiz-Pena Ph.D.; Julie K. Allen; Rebecca L. Stone, M.D.; Alpa M. Nick, M.D.; Yvonne G. Lin, M.D.; Liz Y. Han, M.D.; Lingegowda S. Mangala; Gabriel J. Villares; Pablo Vivas-Mejia, Ph.D.; Christian Rodriguez, Ph.D.; Archana S. Nagaraja; Kshipa M. Gharpure; Mian M.K. Shazhad, M.D.; Maya Zigler; Michael T. Deavers, M.D.; Gary E. Gallick, Ph.D; Menashe Bar-Eli, Ph.D.; and Gabriel Lopez-Berestein, M.D. Sood, Allen, Villares, Nagaraja, Gharpure and Zigler are also affiliated with The University of Texas Health Science Center. Other co-authors included Madeline Torres-Lugo, Ph.D., Gustavo E. Lopez, Ph.D. and Anthony Cruz, University of Puerto Rico; Zheng Wu, Ph.D., Robert D. English, Ph.D., Kizhake V. Soman, Ph.D. and John E. Wiktorowicz, Ph.D., University of Texas Medical Branch; Alexander Zien, Ph.D., Theodoros G. Soldatos and David B. Jackson, Molecular Health GmbH; Tom Young, Ph.D., Lehman College; Koen De Geest, M.D. and Susan K. Lutgendorf, Ph.D., University of Iowa; Steve W. Cole, Ph.D., University of California, Los Angeles.
University of Texas M. D. Anderson Cancer Center
Article adapted by Medical News Today from original press release. Click 'references' tab above for source.
Visit our Ovarian Cancer category page for the latest news on this subject.
Please use one of the following formats to cite this article in your essay, paper or report:
University of Texas M. D. Anderson Cancer Center. "'Master' Proto-Oncogene Identified That Regulates Ovarian Cancer Metastasis." Medical News Today. MediLexicon, Intl., 1 Feb. 2013. Web.
12 Mar. 2014. <http://www.medicalnewstoday.com/releases/255616>
University of Texas M. D. Anderson Cancer Center. (2013, February 1). "'Master' Proto-Oncogene Identified That Regulates Ovarian Cancer Metastasis." Medical News Today. Retrieved from
Please note: If no author information is provided, the source is cited instead.
If you write about specific medications, operations, or procedures please do not name healthcare professionals by name.
For any corrections of factual information, or to contact our editorial team, please use our feedback form. Please send any medical news or health news press releases to:
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
This page was printed from: http://www.medicalnewstoday.com/releases/255616.php
Visit www.medicalnewstoday.com for medical news and health news headlines posted throughout the day, every day.
© 2004-2014 All rights reserved. MNT (logo) is the registered trade mark of MediLexicon International Limited.